Brief: Integra Lifesciences Holdings Third Quarter Revenues Of $385 Million Decreased 0.4% On A Reported Basis

Integra LifeSciences Holdings

26/10/2022 11:36

Oct 26 (Reuters) - Integra Lifesciences Holdings Corp
 IART.O :
    * INTEGRA LIFESCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
    * THIRD QUARTER REVENUES OF $385 MILLION DECREASED 0.4% ON A
REPORTED BASIS
    * QTRLY EARNINGS PER DILUTED SHARE OF $0.60
    * QTRLY ADJUSTED EARNINGS PER DILUTED SHARE OF $0.86
    * THE COMPANY IS RAISING ITS EARNINGS PER SHARE OUTLOOK TO A
RANGE
OF $3.29 TO $3.33 FOR FY2022
    * REAFFIRMING ITS FULL-YEAR 2022 REVENUE GUIDANCE
    * FOR FOURTH QUARTER 2022, THE COMPANY EXPECTS REPORTED
REVENUES
IN THE RANGE OF $391 MILLION TO $403 MILLION
    * Q3 EARNINGS PER SHARE VIEW $0.72, REVENUE VIEW $378.3
MILLION --
REFINITIV IBES DATA
    * FY2022 EARNINGS PER SHARE VIEW $3.15, REVENUE VIEW $1.56
BILLION
-- REFINITIV IBES DATA
    * Q4 ADJUSTED EARNINGS PER DILUTED SHARE IS EXPECTED TO BE
IN A
RANGE OF $0.87 TO $0.91
    * Q4 EARNINGS PER SHARE VIEW $0.88, REVENUE VIEW $403.5
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX74fmS0 
Further company coverage:  IART.O 
 ((Reuters.Briefs@thomsonreuters.com;))